Objective: To study the effect of pioglitazone on mitochondrial Ca2+ and cytochrome c (cyt c) in early diabetic rats, and to explore its mechanism of protecting kidney. Methods: 72 DM rats were randomly divided into n...Objective: To study the effect of pioglitazone on mitochondrial Ca2+ and cytochrome c (cyt c) in early diabetic rats, and to explore its mechanism of protecting kidney. Methods: 72 DM rats were randomly divided into negative control group (NC group), negative control+ pioglitazone intervention group (NCP group), diabetes group (DM group) and diabetes +pioglitazone intervention group (DMP group). In NCP and DMP groups, pioglitazone was administered to the stomach, blood glucose, renal mass index, 24-h urine protein, glomerular morphologic indice, glomerular base-membrane thickness and other indexes were measured, and the contents of Ca2+ and Cyt C in renal tissue were measured. Results: (1) the renal metabolism index, glomerular morphologic indice, glomerular base-membrane thickness of DM group was significantly higher than that of NC group (P < 0.01). The renal metabolism index, glomerular morphologic indice, glomerular base-membrane thickness of DMP group was significantly lower than that of DM group, the difference between the two groups was significant(P<0.05). (2) in DM group, mitochondrial Ca2+ and cytoplasmic cytc were higher than those in NC group, while mitochondrial cytc was lower than that in control group. There was significant difference between the two groups (P < 0.05). In DMP group, mitochondrial Ca2+ and cytoplasmic cytc were lower than those in DM group, while mitochondrial cytc was higher than that in control group. There was significant difference between the two groups (P <0.05). Conclusion: Pioglitazone treatment can reduce the release of mitochondrial cytochrome C and maintain mitochondrial calcium homeostasis.展开更多
基金Key medical and health project of nanjing military region
文摘Objective: To study the effect of pioglitazone on mitochondrial Ca2+ and cytochrome c (cyt c) in early diabetic rats, and to explore its mechanism of protecting kidney. Methods: 72 DM rats were randomly divided into negative control group (NC group), negative control+ pioglitazone intervention group (NCP group), diabetes group (DM group) and diabetes +pioglitazone intervention group (DMP group). In NCP and DMP groups, pioglitazone was administered to the stomach, blood glucose, renal mass index, 24-h urine protein, glomerular morphologic indice, glomerular base-membrane thickness and other indexes were measured, and the contents of Ca2+ and Cyt C in renal tissue were measured. Results: (1) the renal metabolism index, glomerular morphologic indice, glomerular base-membrane thickness of DM group was significantly higher than that of NC group (P < 0.01). The renal metabolism index, glomerular morphologic indice, glomerular base-membrane thickness of DMP group was significantly lower than that of DM group, the difference between the two groups was significant(P<0.05). (2) in DM group, mitochondrial Ca2+ and cytoplasmic cytc were higher than those in NC group, while mitochondrial cytc was lower than that in control group. There was significant difference between the two groups (P < 0.05). In DMP group, mitochondrial Ca2+ and cytoplasmic cytc were lower than those in DM group, while mitochondrial cytc was higher than that in control group. There was significant difference between the two groups (P <0.05). Conclusion: Pioglitazone treatment can reduce the release of mitochondrial cytochrome C and maintain mitochondrial calcium homeostasis.
